Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for liver tumors

N M Carroll1, K K Tanabe

  • 1Division of Surgical Oncology, Department of Surgery, Harvard Medical School, Boston, Massachusetts, USA.

Surgical Oncology Clinics of North America
|June 13, 1998
PubMed
Summary

Gene therapy offers a novel approach to treating liver cancer by targeting tumor cells while preserving healthy liver tissue. This strategy aims to improve cure rates for primary and metastatic liver tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HSV-1 as a novel therapy for breast cancer meningeal metastases.

Cancer gene therapy·2015
Same author

Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review.

The British journal of dermatology·2013
Same author

Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.

Cancer gene therapy·2013
Same author

Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation.

Cancer gene therapy·2011
Same author

Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2010
Same author

Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice.

Cancer gene therapy·2008

Area of Science:

  • Oncology
  • Hepatology
  • Gene Therapy

Background:

  • The liver is a frequent site for both primary malignancies and metastases from solid tumors.
  • Current cure rates for primary and metastatic liver tumors remain low.
  • Novel therapeutic strategies are needed to improve patient outcomes.

Purpose of the Study:

  • To review gene therapy as a novel approach for liver cancer treatment.
  • To explore strategies for tumor-specific cytolysis in the liver.
  • To highlight the goal of eradicating tumor cells while preserving normal liver function.

Main Methods:

  • Review of existing literature on gene therapy for liver cancer.
  • Analysis of strategies exploiting differences between tumor cells and hepatocytes.
  • Examination of methods for tumor-specific cytolysis.

Main Results:

  • Gene therapy presents a promising avenue for liver cancer treatment.
  • Strategies focus on exploiting molecular differences for targeted therapy.
  • The review covers various approaches for selective tumor cell destruction.

Conclusions:

  • Gene therapy holds potential for improving liver cancer treatment outcomes.
  • Targeted cytolysis strategies aim for efficacy with minimal damage to healthy liver tissue.
  • Further research and development in gene therapy are crucial for clinical application.

Related Experiment Videos